跳至主要内容
临床试验/TCTR20221202001
TCTR20221202001已完成1 期

Effects of an integrated rehabilitation program on fatigue in patients with pulmonary tuberculosis: A single-centre randomized controlled trial

/A0 个研究点目标入组 68 人开始时间: 2022年12月2日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
68

研究概览

简要总结

Before the experiment, The experimental group had a mean score of fatigue (mean 5.47, SD 1.99) and the control group (mean 5.46, SD 1.63). After the 3rd week of trial, the mean scores of the experimental group decreased (mean 4.56, SD 2.01) and the control group (mean 5.54, SD 1.92). At the end of the trial at week 6, the experimental group had mean score of fatigue (mean 3.52, SD 1.98) and the control group had mean score of fatigue.(mean 5.09, SD 2.03)

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 N/A (No limit)(—)
性别
All

入选标准

  • Patients with pulmonary tuberculosis receiving antituberculosis drugs who were 18 years of age or older and had been treated for 2 weeks or more, experience with fatigue, ability to continue daily routines for at least 6 minutes without getting tired, no restrictions on walking and exercising, no cognitive impairment, ability to use the LINE application and communicate by speaking, reading and writing in Thai.

排除标准

  • Patients with comorbidities causing simple fatigue, such as AIDS, cancer with chemotherapy or radiotherapy, emphysema, asthma Stage 4 kidney failure and up, congestive heart failure, a history of COVID-19 infection, a psychiatric disorder and sleep apnea.

研究者

发起方
/A

相似试验